CLOs on the Move

Child Health Corporation Of America

www.chca.com

 
Child Health Corporation of America (CHCA) is a legacy business alliance of children's hospitals. CHCA children's hospitals represented more than 20,000 physicians, 100,000 employees, $14 billion in revenue and $1.8 billion in overall medical, surgical and pharmaceutical products. CHCA's former Owner Hospitals are North America's leading children's hospitals and are widely known for their excellence in caring for America's children. In 2011, CHCA, the National Association of Children's Hospitals and Related Institutions (NACHRI) and its public policy affiliate National Association of Children's Hospitals (N.A.C.H.) merged to pool our strengths and talents, creating a new organization, the Children’s Hospital Association. We share members, a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.chca.com
  • 6803 West 64th St. Suite 208
    Shawnee Mission, KS USA 66202
  • Phone: 913.262.1436

Executives

Name Title Contact Details

Similar Companies

Eurogentec North America

Eurogentec North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

uBiome

uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Juvly

Juvly Aesthetics is the fastest growing aesthetics practice in the United States, expanding since 2014, from a single location in Columbus, Ohio to eleven locations across the United States! Our team has gone from servicing just 10 clients to over 53,000 in five short years! The core of this growth stems from our unique values, which include; providing fantastic, natural-beauty enhancing results, transparent prices, and excellent customer service. Whether you are a client looking for first class services, or an eager employment-seeker, Juvly is the place for you!

LifeSeasons

Supplements that address your changing health needs through every phase of life. Formulated for Life. Get in touch: Help@LifeSeasons.com.